ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 77 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $994,165 | +4.0% | 300,352 | +2.7% | 0.00% | – |
Q1 2024 | $956,105 | -8.4% | 292,387 | -1.7% | 0.00% | -100.0% |
Q4 2023 | $1,044,001 | -47.0% | 297,436 | +0.9% | 0.00% | 0.0% |
Q3 2023 | $1,969,098 | -18.6% | 294,775 | +2.2% | 0.00% | 0.0% |
Q2 2023 | $2,418,879 | +8.7% | 288,305 | +28.7% | 0.00% | 0.0% |
Q1 2023 | $2,224,856 | +39.3% | 224,054 | -2.4% | 0.00% | 0.0% |
Q4 2022 | $1,597,000 | +30.4% | 229,454 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,225,000 | +33.7% | 229,454 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $916,000 | -30.3% | 229,454 | -22.4% | 0.00% | 0.0% |
Q1 2022 | $1,315,000 | +26.0% | 295,827 | +13.4% | 0.00% | – |
Q4 2021 | $1,044,000 | -54.2% | 260,976 | +0.6% | 0.00% | -100.0% |
Q3 2021 | $2,278,000 | -22.8% | 259,424 | -0.3% | 0.00% | 0.0% |
Q2 2021 | $2,949,000 | -17.2% | 260,324 | -13.1% | 0.00% | -50.0% |
Q1 2021 | $3,560,000 | +73.2% | 299,633 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $2,055,000 | +53.9% | 299,633 | +66.3% | 0.00% | 0.0% |
Q3 2020 | $1,335,000 | +302.1% | 180,224 | +126.5% | 0.00% | – |
Q2 2020 | $332,000 | +730.0% | 79,557 | +383.4% | 0.00% | – |
Q1 2020 | $40,000 | -79.5% | 16,457 | -51.5% | 0.00% | – |
Q4 2019 | $195,000 | +146.8% | 33,902 | +123.6% | 0.00% | – |
Q3 2019 | $79,000 | -50.6% | 15,160 | -43.6% | 0.00% | – |
Q2 2019 | $160,000 | -50.3% | 26,882 | -25.0% | 0.00% | – |
Q1 2019 | $322,000 | -1.8% | 35,848 | -9.6% | 0.00% | – |
Q4 2018 | $328,000 | -67.1% | 39,658 | -45.1% | 0.00% | – |
Q3 2018 | $996,000 | +124.3% | 72,284 | +29.2% | 0.00% | – |
Q2 2018 | $444,000 | +3936.4% | 55,944 | +3190.8% | 0.00% | – |
Q4 2017 | $11,000 | -80.7% | 1,700 | -78.8% | 0.00% | – |
Q3 2017 | $57,000 | +46.2% | 8,000 | +0.5% | 0.00% | – |
Q1 2017 | $39,000 | – | 7,961 | +27351.7% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 29 | -98.9% | 0.00% | – |
Q1 2015 | $25,000 | – | 2,530 | +3514.3% | 0.00% | – |
Q2 2014 | $0 | – | 70 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |